The drug-coated balloon catheter system is being compared with a sham device in a double-blinded randomized trial.
Jason M. Broderick and Cheryl Guttman Krader, BS, Pharm
Advertisement
Articles by Jason M. Broderick and Cheryl Guttman Krader, BS, Pharm
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants RMAT designation to EG110A for neurogenic detrusor overactivity
2
FAQs: The 2026 AUA Guideline on Medical Management of Kidney Stones
3
PSMA-PET in clinical practice: Juan Gómez Rivas, MD, on barriers to access
4
Managing BPH Before Prostate Radiotherapy: Options Compared
5